Literature DB >> 30014204

Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.

S Keller1,2, J Sedlacik3, T Schuler4, R Buchert4, M Avanesov4, R Zenouzi5, A W Lohse5, H Kooijman6, J Fiehler3, C Schramm5, J Yamamura4.   

Abstract

PURPOSE: To assess the diagnostic value of multiparametric magnetic resonance imaging (MRI) including dynamic Gd-EOB-DTPA-enhanced (DCE) and diffusion-weighted (DW) imaging for diagnosis and staging of hepatic fibrosis in primary sclerosing cholangitis (PSC) using transient elastography as a standard reference.
MATERIAL AND METHODS: Multiparametric MRI was prospectively performed on a 3.0-Tesla scanner in 47 patients (age 43.9±14.3 years). Transient elastography derived liver stiffness measurements (LSM), DCE-MRI derived parameters (hepatocellular uptake rate (Ki), arterial (Fa), portal venous (Fv) and total (Ft) blood flow, mean transit time (MTT), and extracellular volume (Ve)) and the apparent diffusion coefficient (ADC) were calculated. Correlation and univariate analysis of variance with post hoc pairwise comparison were applied to test for differences between LSM derived fibrosis stages (F0/F1, F2/3, F4). ROC curve analysis was used as a performance measure.
RESULTS: Both ADC and Ki correlated significantly with LSM (r= -0.614; p<0.001 and r= -0.368; p=0.01). The ADC significantly discriminated fibrosis stages F0/1 from F2/3 and F4 (p<0.001). Discrimination of F0/1 from F2/3 and F4 reached a sensitivity/specificity of 0.917/0.821 and 0.8/0.929, respectively. Despite significant inter-subject effect for classification of fibrosis stages, post hoc pairwise comparison was not significant for Ki (p>0.096 for F0/1 from F2/3 and F4). LSM, ADC and Ki were significantly associated with serum-based liver functional tests, disease duration and spleen volume.
CONCLUSION: DW-MRI provides a higher diagnostic performance for detection of hepatic fibrosis and cirrhosis in PSC patients in comparison to Gd-EOB-DTPA-enhanced DCE-MRI. KEY POINTS: • Both ADC and hepatocellular uptake rate (Ki) correlate significantly with liver stiffness (r= -0.614; p<0.001 and r= -0.368; p=0.01). • The DCE-imaging derived quantitative parameter hepatocellular uptake rate (Ki) fails to discriminate pairwise intergroup differences of hepatic fibrosis (p>0.09). • DWI is preferable to DCE-imaging for discrimination of fibrosis stages F0/1 to F2/3 (p<0.001) and F4 (p<0.001).

Entities:  

Keywords:  Diffusion magnetic resonance imaging; Gadolinium ethoxybenzyl DTPA; Liver fibrosis; Magnetic resonance imaging; Primary sclerosing cholangitis

Mesh:

Substances:

Year:  2018        PMID: 30014204     DOI: 10.1007/s00330-018-5614-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  47 in total

1.  Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Authors:  Martin Rohrer; Hans Bauer; Jan Mintorovitch; Martin Requardt; Hanns-Joachim Weinmann
Journal:  Invest Radiol       Date:  2005-11       Impact factor: 6.016

2.  Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.

Authors:  Bachir Taouli; Anuj J Tolia; Mariela Losada; James S Babb; Edwin S Chan; Michael A Bannan; Hillel Tobias
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

3.  Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

Authors:  Laurent Huwart; Christine Sempoux; Eric Vicaut; Najat Salameh; Laurence Annet; Etienne Danse; Frank Peeters; Leon C ter Beek; Jacques Rahier; Ralph Sinkus; Yves Horsmans; Bernard E Van Beers
Journal:  Gastroenterology       Date:  2008-04-04       Impact factor: 22.682

4.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

5.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

6.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

Authors:  Marianne Ziol; Adriana Handra-Luca; Adrien Kettaneh; Christos Christidis; Frédéric Mal; Farhad Kazemi; Victor de Lédinghen; Patrick Marcellin; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

7.  Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma.

Authors:  Frank T C Tschirch; Anja Struwe; Henrik Petrowsky; Irini Kakales; Borut Marincek; Dominik Weishaupt
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

8.  Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.

Authors:  Maïté Lewin; Armelle Poujol-Robert; Pierre-Yves Boëlle; Dominique Wendum; Elisabeth Lasnier; Magalie Viallon; Jérôme Guéchot; Christine Hoeffel; Lionel Arrivé; Jean-Michel Tubiana; Raoul Poupon
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

9.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

10.  Efficacy of non-invasive elastometry on staging of hepatic fibrosis.

Authors:  Hidetsugu Saito; Shinichiro Tada; Nobuhiro Nakamoto; Kumi Kitamura; Hitomi Horikawa; Satoshi Kurita; Yoshimasa Saito; Hirokata Iwai; Hiromasa Ishii
Journal:  Hepatol Res       Date:  2004-06       Impact factor: 4.288

View more
  3 in total

1.  Quantitative diffusion MRI of the abdomen and pelvis.

Authors:  Diego Hernando; Yuxin Zhang; Ali Pirasteh
Journal:  Med Phys       Date:  2021-10-08       Impact factor: 4.506

2.  Inter- and intra-reader agreement for gadoxetic acid-enhanced MRI parameter readings in patients with chronic liver diseases.

Authors:  Lucian Beer; Mattias Mandorfer; Nina Bastati; Sarah Poetter-Lang; Dietmar Tamandl; Dilyana Plamenova Stoyanova; Michael Christoph Elmer; Georg Semmler; Benedikt Simbrunner; Jacqueline C Hodge; Claude B Sirlin; Thomas Reiberger; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2019-04-18       Impact factor: 5.315

3.  Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.

Authors:  Sudhakar K Venkatesh; Christopher L Welle; Frank H Miller; Kartik Jhaveri; Kristina I Ringe; John E Eaton; Helen Bungay; Lionel Arrivé; Ahmed Ba-Ssalamah; Aristeidis Grigoriadis; Christoph Schramm; Ann S Fulcher
Journal:  Eur Radiol       Date:  2021-08-06       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.